Last €8.60 EUR
Change Today -0.80 / -8.51%
Volume 0.0
IM8N On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:50 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

insmed inc (IM8N) Snapshot

Open
€9.58
Previous Close
€9.40
Day High
€9.58
Day Low
€8.60
52 Week High
05/23/13 - €9.61
52 Week Low
06/1/12 - €2.21
Market Cap
--
Average Volume 10 Days
328.1
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSMED INC (IM8N)

insmed inc (IM8N) Latest News

More News

insmed inc (IM8N) Related Businessweek News

No Related Businessweek News Found

insmed inc (IM8N) Details

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company’s Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.

41 Employees
Last Reported Date: 03/18/13
Founded in 1999

insmed inc (IM8N) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $212.2K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $87.7K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $595.8K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $409.7K
Compensation as of Fiscal Year 2012.

insmed inc (IM8N) Key Developments

Insmed Incorporated Presents at Merrill Lynch 2013 Health Care Conference, May-16-2013 11:20 AM

Insmed Incorporated Presents at Merrill Lynch 2013 Health Care Conference, May-16-2013 11:20 AM. Venue: Encore at Wynn, 3121 Las Vegas Blvd South, Las Vegas, Nevada, United States. Speakers: William H. Lewis, Chief Executive Officer, President and Director.

Insmed Incorporated Presents at UBS Global Healthcare Conference, May-20-2013 02:00 PM

Insmed Incorporated Presents at UBS Global Healthcare Conference, May-20-2013 02:00 PM. Venue: Sheraton New York Hotel, 811 Seventh Avenue, New York, New York, United States. Speakers: Andrew T. Drechsler, Chief Financial Officer and Principal Accounting Officer, William H. Lewis, Chief Executive Officer, President and Director.

Insmed Incorporated Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013; Provides Financial Guidance for the Year 2013

Insmed Incorporated announced unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the first quarter of 2013, Insmed posted a net loss of $13.7 million or $0.43 per basic and diluted share compared with a net loss of $6.8 million or $0.28 per basic and diluted share for the first quarter of 2012. Operating loss was $14.3 million against $7.3 million and loss before income taxes was $14.9 million against $6.8 million reported last year. The company estimates that its full year 2013 cash requirements to fund operations will be in the range of $45 million to $55 million. The company expects current cash balances will be sufficient to fund operations into 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IM8N:GR €8.60 EUR -0.80

IM8N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Gilead Sciences Inc $55.81 USD +0.33
Novartis AG SFr.71.25 CHF -0.20
View Industry Companies
 

Industry Analysis

IM8N

Industry Average

Valuation IM8N Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSMED INC, please visit www.insmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.